BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm

Local health authorities reported thousands of cases within weeks; by early August, figures converged around the several-thousand mark, with some reports t...

August 11, 2025 | Analysis

Fighting Dengue in a Changing Climate: Takeda’s Vision for Resilient Health Systems in Emerging Markets

Dengue is no longer a seasonal threat. It is a growing climate-driven crisis. With rising global temperatures, shifting rainfall patterns and rapid urbanis...

August 04, 2025 | Expert Insight

Energenesis Completes Phase I Trial of ENERGI-F705PD, a Novel Oral Therapy for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pha...

August 04, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

Precision Medicine – Are We Ready for It?

Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...

July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India

OMRON, bolttech and QBE Launch Premium Care Plan in Singapore to Empower Proactive Heart Health

Global insurtech bolttech and OMRON Healthcare Singapore, a global leader in innovative medical equipment for health monitoring and the...

July 22, 2025 | News

Hyphens Pharma Launches Winlevi® in Singapore and Malaysia, Ushering in a New Era of Acne Treatment in Southeast Asia

Hyphens Pharma Pte. Ltd., a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 18, 2025 | News

Using NLP-Driven Decision Support in Emergency Health Assistance

According to the US Department of Transportation, over 40,000 lives were lost in roadway deaths in 2023. The CDC reports that the country saw appro...

July 14, 2025 | News

Southeast Asia Poised to Lead AI-Driven Healthcare Transformation Amid Rising Cross-Border Collaboration

The Southeast Asia (SEA) region’s role in healthcare innovation, long bolstered by Singapore’s commitment to serve as a g...

July 01, 2025 | Opinion | By Chu Canh Chieu, FPT Software Managing Director of Global Healthcare Center, FPT Corporation

Novo Nordisk Launches Anti-Obesity Drug Wegovy in India for Chronic Weight Management and Cardiovascular Risk Reduction

Danish pharmaceutical major Novo Nordisk has officially launched its anti-obesity therapy Wegovy in India. The once-weekly injectable treatment is approved...

June 24, 2025 | News

Immuno Cure and PharmaJet Partner on Needle-Free HIV Therapeutic Vaccine Study in Hong Kong

Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboratio...

June 20, 2025 | News

MSD Launches Phase 3 MOBILIZE-1 Trial for Single-Dose Dengue Vaccine V181 in Asia-Pacific

MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dos...

June 16, 2025 | News

Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms

Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...

June 04, 2025 | News

XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders

XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell the...

June 03, 2025 | News

Stay Connected